Cargando…

Delayed revascularization in acute ischemic stroke patients

Stroke shares a significant burden of global mortality and disability. A significant decline in the quality of life is attributed to the so-called post-stroke cognitive impairment including mild to severe cognitive alterations, dementia, and functional disability. Currently, only two clinical interv...

Descripción completa

Detalles Bibliográficos
Autores principales: Eastin, T. Marc, Dye, Justin A., Pillai, Promod, Lopez-Gonzalez, Miguel A., Huang, Lei, Zhang, John H., Boling, Warren W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945110/
https://www.ncbi.nlm.nih.gov/pubmed/36843940
http://dx.doi.org/10.3389/fphar.2023.1124263
_version_ 1784892068670210048
author Eastin, T. Marc
Dye, Justin A.
Pillai, Promod
Lopez-Gonzalez, Miguel A.
Huang, Lei
Zhang, John H.
Boling, Warren W.
author_facet Eastin, T. Marc
Dye, Justin A.
Pillai, Promod
Lopez-Gonzalez, Miguel A.
Huang, Lei
Zhang, John H.
Boling, Warren W.
author_sort Eastin, T. Marc
collection PubMed
description Stroke shares a significant burden of global mortality and disability. A significant decline in the quality of life is attributed to the so-called post-stroke cognitive impairment including mild to severe cognitive alterations, dementia, and functional disability. Currently, only two clinical interventions including pharmacological and mechanical thrombolysis are advised for successful revascularization of the occluded vessel. However, their therapeutic effect is limited to the acute phase of stroke onset only. This often results in the exclusion of a significant number of patients who are unable to reach within the therapeutic window. Advances in neuroimaging technologies have allowed better assessment of salvageable penumbra and occluded vessel status. Improvement in diagnostic tools and the advent of intravascular interventional devices such as stent retrievers have expanded the potential revascularization window. Clinical studies have demonstrated positive outcomes of delayed revascularization beyond the recommended therapeutic window. This review will discuss the current understanding of ischemic stroke, the latest revascularization doctrine, and evidence from clinical studies regarding effective delayed revascularization in ischemic stroke.
format Online
Article
Text
id pubmed-9945110
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99451102023-02-23 Delayed revascularization in acute ischemic stroke patients Eastin, T. Marc Dye, Justin A. Pillai, Promod Lopez-Gonzalez, Miguel A. Huang, Lei Zhang, John H. Boling, Warren W. Front Pharmacol Pharmacology Stroke shares a significant burden of global mortality and disability. A significant decline in the quality of life is attributed to the so-called post-stroke cognitive impairment including mild to severe cognitive alterations, dementia, and functional disability. Currently, only two clinical interventions including pharmacological and mechanical thrombolysis are advised for successful revascularization of the occluded vessel. However, their therapeutic effect is limited to the acute phase of stroke onset only. This often results in the exclusion of a significant number of patients who are unable to reach within the therapeutic window. Advances in neuroimaging technologies have allowed better assessment of salvageable penumbra and occluded vessel status. Improvement in diagnostic tools and the advent of intravascular interventional devices such as stent retrievers have expanded the potential revascularization window. Clinical studies have demonstrated positive outcomes of delayed revascularization beyond the recommended therapeutic window. This review will discuss the current understanding of ischemic stroke, the latest revascularization doctrine, and evidence from clinical studies regarding effective delayed revascularization in ischemic stroke. Frontiers Media S.A. 2023-02-08 /pmc/articles/PMC9945110/ /pubmed/36843940 http://dx.doi.org/10.3389/fphar.2023.1124263 Text en Copyright © 2023 Eastin, Dye, Pillai, Lopez-Gonzalez, Huang, Zhang and Boling. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Eastin, T. Marc
Dye, Justin A.
Pillai, Promod
Lopez-Gonzalez, Miguel A.
Huang, Lei
Zhang, John H.
Boling, Warren W.
Delayed revascularization in acute ischemic stroke patients
title Delayed revascularization in acute ischemic stroke patients
title_full Delayed revascularization in acute ischemic stroke patients
title_fullStr Delayed revascularization in acute ischemic stroke patients
title_full_unstemmed Delayed revascularization in acute ischemic stroke patients
title_short Delayed revascularization in acute ischemic stroke patients
title_sort delayed revascularization in acute ischemic stroke patients
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945110/
https://www.ncbi.nlm.nih.gov/pubmed/36843940
http://dx.doi.org/10.3389/fphar.2023.1124263
work_keys_str_mv AT eastintmarc delayedrevascularizationinacuteischemicstrokepatients
AT dyejustina delayedrevascularizationinacuteischemicstrokepatients
AT pillaipromod delayedrevascularizationinacuteischemicstrokepatients
AT lopezgonzalezmiguela delayedrevascularizationinacuteischemicstrokepatients
AT huanglei delayedrevascularizationinacuteischemicstrokepatients
AT zhangjohnh delayedrevascularizationinacuteischemicstrokepatients
AT bolingwarrenw delayedrevascularizationinacuteischemicstrokepatients